(Last updated : 2020-04-08 10:44:50)
  深澤 拓也
   Department     ,
   Position  
■ Present specialized field
Molecular biology 
■ Journal
1. 2018/06 Development of an integrated CRISPRi targeting Np63 for treatment of squamous cell carcinoma. 
2. 2017/11 Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma. 
3. 2017/10 Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma. 
4. 2017/03 Gene signature driving invasive mucinous adenocarcinoma of the lung. 
5. 2017/02 A Case of Cholesterol Crystal Embolization with Hemorrhagic Imntestinal Ulcer 
Display all(35)
■ Presentation
1. 2018/09/28 Targeted silencing of SOX2 by an ATF showed antitumor effect in lung and esophageal squamous cell carcinoma  
2. 2018/04/16 Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma  
3. 2017/10/16 TGFALPHA PROMOTES GROWTH OF LUNG TUMORS CARRYING EGFR MUTATION BUT NOT KRAS MUTATION IN TRANSGENIC MOUSE MODELS IN VIVO  
4. 2017/04/03 Development of a novel targeted therapy for malignant mesothelioma carcinoma by a midkine inhibitor.  
5. 2016/10/06 SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma  
Display all(22)
■ Belonging society
1. American Association for Cancer Research